Next Quarterly Earnings
Friday, October 23, 2026
CW 43
Pre-Market
In 57 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
AbbVie
AbbVie is a global, research-based biopharmaceutical company from the US. It researches, develops, and delivers innovative therapies for some of the world's most complex and serious diseases. Focusing on immunology, oncology, and neuroscience, AbbVie improves patients' lives through scientific innovation and commitment.
Recap: the latest results
AbbVie (ABBV) reported its Q2 2026 financial results on July 31, 2026, before market open. The company reported quarterly earnings per share (EPS) of 3.65 USD, beating the analyst estimate of 3.61 USD by 1.2%. Quarterly revenue reached 16990 million USD. Following the publication, the stock price fell by 2.51%.
Generated automatically from our data — as of 08/06/2026 Read the article →
Frequently asked questions
When will AbbVie report its next quarterly earnings?
AbbVie is scheduled to report its next quarterly earnings on 10/23/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did AbbVie last report quarterly earnings?
AbbVie last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 3.65 USD.
How does AbbVie stock react to earnings?
Across its last 5 earnings reports, AbbVie stock moved by ±3.7% on average the following day. The largest reaction was +4.7% on 01/31/2025; 2 of 5 reactions were positive.
How often has AbbVie beaten expectations?
AbbVie has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
How do I add the AbbVie earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±3.7%
Avg. next-day move
+4.7%
Largest move (01/31/2025)
40%
Share of positive reactions
±4.5%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
5/5
Quarters above estimates
100%
Beat rate
+1.1%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
AbbVie
Country
🇺🇸
More Financial Information